SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-000030
Filing Date
2023-01-03
Accepted
2023-01-03 07:15:24
Documents
49
Period of Report
2022-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10046080_8k.htm   iXBRL 8-K 43567
2 EXHIBIT 10.1 brhc10046080_ex10-1.htm EX-10.1 39511
3 EXHIBIT 99.1 brhc10046080_ex99-1.htm EX-99.1 28104
4 EXHIBIT 99.2 brhc10046080_ex99-2.htm EX-99.2 68380
8 brhc10046080_ex99-2slide1.jpg GRAPHIC 47169
9 brhc10046080_ex99-2slide2.jpg GRAPHIC 268975
10 brhc10046080_ex99-2slide3.jpg GRAPHIC 93059
11 brhc10046080_ex99-2slide4.jpg GRAPHIC 154466
12 brhc10046080_ex99-2slide5.jpg GRAPHIC 67549
13 brhc10046080_ex99-2slide6.jpg GRAPHIC 39665
14 brhc10046080_ex99-2slide7.jpg GRAPHIC 104711
15 brhc10046080_ex99-2slide8.jpg GRAPHIC 105773
16 brhc10046080_ex99-2slide9.jpg GRAPHIC 87551
17 brhc10046080_ex99-2slide10.jpg GRAPHIC 96782
18 brhc10046080_ex99-2slide11.jpg GRAPHIC 86982
19 brhc10046080_ex99-2slide12.jpg GRAPHIC 82742
20 brhc10046080_ex99-2slide13.jpg GRAPHIC 44112
21 brhc10046080_ex99-2slide14.jpg GRAPHIC 125754
22 brhc10046080_ex99-2slide15.jpg GRAPHIC 69063
23 brhc10046080_ex99-2slide16.jpg GRAPHIC 55544
24 brhc10046080_ex99-2slide17.jpg GRAPHIC 101386
25 brhc10046080_ex99-2slide18.jpg GRAPHIC 106283
26 brhc10046080_ex99-2slide19.jpg GRAPHIC 102700
27 brhc10046080_ex99-2slide20.jpg GRAPHIC 87708
28 brhc10046080_ex99-2slide21.jpg GRAPHIC 91404
29 brhc10046080_ex99-2slide22.jpg GRAPHIC 72566
30 brhc10046080_ex99-2slide23.jpg GRAPHIC 100170
31 brhc10046080_ex99-2slide24.jpg GRAPHIC 70544
32 brhc10046080_ex99-2slide25.jpg GRAPHIC 72367
33 brhc10046080_ex99-2slide26.jpg GRAPHIC 90636
34 brhc10046080_ex99-2slide27.jpg GRAPHIC 40666
35 brhc10046080_ex99-2slide28.jpg GRAPHIC 55603
36 brhc10046080_ex99-2slide29.jpg GRAPHIC 65304
37 brhc10046080_ex99-2slide30.jpg GRAPHIC 61988
38 brhc10046080_ex99-2slide31.jpg GRAPHIC 76244
39 brhc10046080_ex99-2slide32.jpg GRAPHIC 91654
40 brhc10046080_ex99-2slide33.jpg GRAPHIC 46605
41 image00001.jpg GRAPHIC 3325
  Complete submission text file 0001140361-23-000030.txt   4308203

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20221230.xsd EX-101.SCH 3872
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20221230_lab.xml EX-101.LAB 22547
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20221230_pre.xml EX-101.PRE 16049
43 EXTRACTED XBRL INSTANCE DOCUMENT brhc10046080_8k_htm.xml XML 4239
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 23500186
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences